Search
Beam Therapeutics Inc
BEAMAdd to Watchlist
24.670USD
+1.570+6.80%
Close 09-17 16:00（ET）
2.55BMarket Cap
LossP/E TTM
After-hours 19:54 (ET)24.950USD+0.295+1.20%
After-hours 19:54 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+6.80%
5 Days
+1.23%
1 Month
-8.97%
6 Months
-4.49%
Year to Date
-11.00%
1 Year
+9.89%
Key Figures
24.280Open
25.450High
111.26KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.11%Turnover Ratio
23.100Prev. Close
24.130Low
2.76MTurnover
LossP/E Static
2.39P/B
0.00%Div Yield TTM
-4.48%ROA
38.26052wk High
24.00Volume Ratio
-376.74MNet Profit
103.26MShares
-0.4908EPS TTM
2.26Beta
-5.77%ROE
20.23052wk Low
5.71%Amplitude
100.00%Gross Margin
2.55BMarket Cap
0.38Reward/Risk
4.68%Risk Rate
More news coming soon, stay tuned...
Beam Therapeutics Inc's Score
-0.04vs previous score
Forecast8.59
Financial Health5.61
Technical4.66
Valuation Dimensions8.30
Institutional Confidence10.00
Risk Assessment5.05
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
Beam Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-1.18/-1.11
Revenue / Forecast
490.00K/16.37M
Beam Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolBEAM
Number of employees483
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| ARK Investment Management LLC | 11.79% |
| Fidelity Management & Research Company LLC | 11.08% |
| Farallon Capital Management, L.L.C. | 9.78% |
| BlackRock Institutional Trust Company, N.A. | 6.80% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 56.36% |
| Investment Advisor/Hedge Fund | 20.88% |
| Hedge Fund | 18.65% |
| Venture Capital | 4.74% |
Related Instruments
+1.28%
+1.10%
+2.00%
+0.58%
+1.55%
+1.60%
+0.91%
+2.17%
+0.66%
+3.55%
+0.60%
-1.19%
+1.53%
+1.29%
-0.87%
+1.92%
+8.55%
+1.13%
+2.20%
-2.67%
FAQs
What is the current price of Beam Therapeutics Inc (BEAM)?
The current price of Beam Therapeutics Inc (BEAM) is 24.67.
What is the symbol of Beam Therapeutics Inc?
The ticker symbol of Beam Therapeutics Inc is BEAM.
What is the 52-week high of Beam Therapeutics Inc?
The 52-week high of Beam Therapeutics Inc is 38.26.
What is the 52-week low of Beam Therapeutics Inc?
The 52-week low of Beam Therapeutics Inc is 20.23.
What is the market capitalization of Beam Therapeutics Inc?
The market capitalization of Beam Therapeutics Inc is 2.55B.
Is Beam Therapeutics Inc (BEAM) currently rated as Buy, Hold, or Sell?
According to analysts, Beam Therapeutics Inc (BEAM) has an overall rating of Buy, with a price target of 51.24.
What is the Earnings Per Share (EPS TTM) of Beam Therapeutics Inc (BEAM)?
The Earnings Per Share (EPS TTM) of Beam Therapeutics Inc (BEAM) is -0.49.